•
Based on evidence from other
squamous cell cancers such
as cervical, head & neck, and
anal cancer, the addition of
concomitant, radiosensitising
chemotherapy to adjuvant
radiotherapy should be
considered.
Grade C: Extrapolated evidence from studies rated as 2++
ESGO 2016